SHL.AX
Sonic Healthcare Limited
ASXAUDEQUITY
Healthcare
DELAYED
Last price
21.08
▼ 0.30 (1.40%)
MARKET · —
Price
Open
20.78
Prev close
21.38
Day high
21.29
Day low
20.40
Volume
3.40M
Market cap
$10.42B
P/E (TTM)
17.14
52W range
18.26 – 24.96
Trailing performance
Returnvs SPY
1W
-5.77%
-4.4%
1M
+1.35%
-2.4%
3M
+11.42%
+8.3%
6M
-8.43%
-19.5%
YTD
-6.77%
-19.1%
1Y
-12.60%
-32.6%
3Y
-34.55%
-108.7%
5Y
-50.66%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$10.42B
Enterprise value$15.76B
Revenue (TTM)$10.87B
Gross profit$3.58B
EBITDA$1.87B
Net income$608.29M
EPS (TTM)$1.23
Free cash flow$736.21M
Total cash$653.69M
Total debt$5.84B
Book value / share$17.33
Shares outstanding494.24M
Float458.25M
Short % of float—
Dividend yield5.12%
Beta (5Y)0.59
Valuation & profitability ratios
Trailing P/E17.14
Forward P/E16.04
PEG ratio2.30
Price / sales—
Price / book1.22
EV / revenue1.45
EV / EBITDA8.41
Gross margin32.99%
Operating margin9.50%
Profit margin5.60%
Return on equity7.50%
Return on assets3.82%
Debt / equity68.76
Current ratio0.99
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total revenue | $10.96B | $9.65B | $9.00B | $8.17B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $608.29M | $513.60M | $511.09M | $684.98M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | $608.29M | $513.60M | $511.09M | $684.98M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.24 | 14 | $11.13B | +1.6% |
| Next year | 1.36 | 15 | $11.60B | +4.2% |
Analyst targets & ownership
Mean target$22.69
High target$28.64
Low target$19.00
Implied upside7.64%
Analyst count16
ConsensusHOLD
Strong buy / Buy1 / 4
Hold8
Sell / Strong sell2 / 1
Held by insiders7.99%
Held by institutions47.68%
Institutions holding265
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
39.48M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 16, 25 | Evans (Nicola Wakefield) Director (Non-Executive) |
BUY | 2.50K | $35.30K | Direct |
| Oct 15, 25 | Giles (Katharine M.D.) Independent Non-Executive Director |
BUY | 1.00K | $13.78K | Direct |
| Oct 3, 25 | Giles (Katharine M.D.) Independent Non-Executive Director |
BUY | 1.00K | $14.34K | Direct |
| Oct 2, 25 | Compton (Mark Raymond) Chairman of the Board |
BUY | 1.50K | $21.34K | Direct |
| Oct 1, 25 | Bennett (Christine) Independent Non-Executive Director |
BUY | 1.10K | $15.64K | Direct |
| Sep 29, 25 | Goldschmidt (Colin Stephen) Chief Executive Officer |
— | 10.22K | — | Direct |
| Sep 29, 25 | Wilks (Christopher David) Director (Executive) |
— | 5.86K | — | Direct |
| Sep 26, 25 | Spargo (Kathryn Dianne) Independent Non-Executive Director |
BUY | 3.50K | $48.72K | Direct |
| Sep 26, 25 | Crowe (Suzanne) Independent Non-Executive Director |
BUY | 2.37K | $32.70K | Direct |
| Sep 2, 25 | Goldschmidt (Colin Stephen) Chief Executive Officer |
— | 9.85K | — | Direct |
| Sep 2, 25 | Wilks (Christopher David) Director (Executive) |
— | 3.75K | — | Direct |
| Apr 9, 25 | Bennett (Christine) Independent Non-Executive Director |
BUY | 1.00K | $15.38K | Direct |
| Apr 8, 25 | Giles (Katharine M.D.) Independent Non-Executive Director |
BUY | 850 | $12.51K | Direct |
| Mar 25, 25 | Evans (Nicola Wakefield) Director (Non-Executive) |
BUY | 2.00K | $32.26K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Bennett (Christine) |
Independent Non-Executive Director | 8.20K | Purchase |
Compton (Mark Raymond) |
Chairman of the Board | 17.02K | Purchase |
Crowe (Suzanne) |
Independent Non-Executive Director | 9.91K | Purchase |
Evans (Nicola Wakefield) |
Director (Non-Executive) | 6.50K | Purchase |
Giles (Katharine M.D.) |
Independent Non-Executive Director | 5.60K | Purchase |
Goldschmidt (Colin Stephen) |
Chief Executive Officer | 1.00M | Other |
Spargo (Kathryn Dianne) |
Independent Non-Executive Director | 31.00K | Purchase |
Wilks (Christopher David) |
Director (Executive) | 608.80K | Other |
Moving averages & technicals
SMA 10
22.39
-5.86% from price
SMA 20
22.25
-5.28% from price
SMA 50
21.42
-1.57% from price
SMA 100
20.46
+3.03% from price
SMA 200
21.38
-1.39% from price
EMA 12
22.20
-5.06% from price
EMA 26
21.99
-4.15% from price
EMA 50
21.53
-2.08% from price
RSI (14)
41.1
Neutral
MACD (12,26,9)
0.21
Hist -0.15
ATR (14)
0.72
3.43% of price
Realised vol 30D
37.0%
Annualised
Bollinger upper
23.38
20, 2σ
Bollinger lower
21.13
20, 2σ
50 / 200 cross
Golden
21.42 vs 21.38
Trend bias
Below 200
-1.39%
Risk profile
Beta vs SPY
0.01
Less volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
37.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.6%
Peak to trough
Max drawdown 5Y
-60.6%
Peak to trough
ATR 14
0.72
3.43% of price
Beta (reported)
0.59
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Enterprise Cash Sweeps: How Large, Multi-Bank Organizations Coordinate Corporate Cash and Capture Yield Across Every Account
GlobeNewswire · 4m ago
New York Court Reviews Judgment Challenge After Halting Sheriff's Sale in Nassau County
GlobeNewswire · 4m ago
Adobe Stock Looks Cheap for a Reason. Here’s Why I’m Buying.
24/7 Wall St. · 6m ago
Swedish police name 17-year-old girl as victim in school sword attack
AFP · 11m ago
Insider Cuts Holdings of Growth Stock Following 78% Rally
Motley Fool · 12m ago
Can Bloom Energy Keep Beating the Market?
Motley Fool · 12m ago
Carrick keeps calm despite Man Utd misery, Sage beaten in first game as Palace boss
AFP · 12m ago
172-year-old luxury giant exits entire market
TheStreet · 14m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.